Current Value
$39.081 Year Return
Current Value
$39.081 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ELVN | 49.43% | $999.66M | +71.93% | 0.00% |
ARWR | 46.87% | $2.25B | -48.56% | 0.00% |
MRSN | 46.54% | $78.32M | -76.61% | 0.00% |
NTLA | 44.15% | $991.50M | -63.62% | 0.00% |
DYN | 43.89% | $1.53B | -10.34% | 0.00% |
DNLI | 43.15% | $2.70B | +2.01% | 0.00% |
ATXS | 42.77% | $415.92M | +0.14% | 0.00% |
IDYA | 42.64% | $1.97B | -43.88% | 0.00% |
RARE | 41.75% | $3.70B | -9.05% | 0.00% |
QTRX | 40.37% | $330.15M | -62.58% | 0.00% |
KYMR | 40.29% | $2.60B | +42.22% | 0.00% |
MCO | 39.69% | $83.82B | +21.18% | 0.73% |
BN | 39.64% | $83.55B | +42.24% | 0.56% |
RVMD | 39.49% | $7.26B | +45.47% | 0.00% |
AXSM | 38.99% | $4.10B | -0.41% | 0.00% |
CLDX | 38.97% | $1.52B | -44.84% | 0.00% |
XNCR | 38.76% | $1.34B | -6.28% | 0.00% |
ACLX | 38.75% | $3.50B | +18.08% | 0.00% |
EDIT | 38.63% | $94.10M | -87.09% | 0.00% |
PLRX | 38.61% | $683.99M | -36.17% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RPRX | -14.81% | $13.34B | +5.70% | 2.78% |
STG | -9.35% | $28.93M | -36.25% | 0.00% |
HUSA | -8.79% | $21.33M | 0.00% | 0.00% |
CME | -8.75% | $83.51B | +16.68% | 4.47% |
ARHS | -6.93% | $1.54B | +2.27% | 0.00% |
HEES | -6.84% | $3.31B | +88.22% | 1.22% |
FRO | -6.59% | $4.11B | -17.15% | 10.39% |
QNTM | -6.47% | $6.30M | -94.46% | 0.00% |
VHC | -6.47% | $28.64M | +23.67% | 0.00% |
TTE | -6.25% | $131.27B | -10.73% | 5.81% |
CVS | -5.45% | $64.90B | -33.39% | 5.14% |
CI | -5.29% | $79.28B | -7.14% | 1.97% |
CMTL | -5.01% | $81.55M | -63.87% | 0.00% |
TRVG | -4.75% | $59.69M | +6.83% | 0.00% |
WBA | -4.66% | $10.58B | -46.48% | 8.16% |
BEST | -4.66% | $31.65M | +5.10% | 0.00% |
CBOE | -4.16% | $20.24B | +5.28% | 1.22% |
FUBO | -4.05% | $1.29B | +43.23% | 0.00% |
WM | -3.91% | $83.15B | +14.60% | 1.44% |
XGN | -3.76% | $52.91M | +47.42% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GO | -0.02% | $1.59B | -40.41% | 0.00% |
CODX | 0.12% | $23.69M | -43.37% | 0.00% |
JBLU | 0.13% | $2.67B | +49.90% | 0.00% |
OCFT | 0.18% | $98.61M | -3.94% | 0.00% |
PRT | -0.18% | $50.49M | -10.61% | 10.10% |
TNK | -0.24% | $1.62B | -13.00% | 2.11% |
SHEL | 0.25% | $205.50B | +6.72% | 4.17% |
DHT | -0.27% | $1.81B | +1.45% | 8.89% |
MSDL | 0.28% | $1.87B | +2.86% | 9.48% |
CNC | -0.29% | $32.01B | -19.46% | 0.00% |
PGNY | -0.31% | $1.71B | -47.73% | 0.00% |
LTM | -0.34% | $8.01B | -100.00% | <0.01% |
PGR | 0.34% | $140.45B | +42.23% | 2.39% |
FLNG | -0.36% | $1.40B | -12.41% | 11.49% |
IMNN | -0.39% | $12.96M | +35.38% | 0.00% |
SCCO | 0.39% | $75.36B | +22.33% | 2.14% |
DOGZ | -0.39% | $558.50M | +1,209.55% | 0.00% |
POAI | -0.44% | $8.00M | -58.19% | 0.00% |
CVX | 0.47% | $281.96B | +9.19% | 4.16% |
CORZ | 0.49% | $3.88B | +1,078.81% | 0.00% |
Finnhub
SAN DIEGO, Jan. 10, 2025 -- Crinetics Pharmaceuticals, Inc. today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards...
Yahoo
Substantial, Rapid and Sustained Statistically Significant Reductions of Key Biomarkers Achieved Across Doses, Including up to 80% Mean Reduction of Androstenedione Meaningful Improvements Demonstrated in Multiple Clinical Signs and Symptoms of CAH Affecting Patient Health Safety and Efficacy Data Support Initiation of Phase 3 Clinical Trial Management to Host Investor Conference Call Today at 8:30 AM ET SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX)
Yahoo
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA on Tuesday, January 14, 2025 at 4:30 p.m. Pacific Time. To access the live webcast, click here. The archived webcast will also be accessible on the Events & Presentations page in the Investors section of the Crineti
SeekingAlpha
Crinetics Pharmaceuticals is set for a fall 2025 launch of paltusotine, with strong Wall Street support despite being overvalued. Explore more details here.
Finnhub
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer SAN DIEGO - December 16, 2024 - Crinetics Pharmaceuticals, Inc. , today announced the...
Yahoo
SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the appointment of Isabel Kalofonos as Chief Commercial Officer. Ms. Kalofonos will lead the company’s commercial strategy and operations for the potential launch of paltusotine, the first and only once-daily, oral, selective somatostatin receptor type 2 nonpeptide agonist for adults living with acromegaly and will lead pre-commercialization activities for the company’s deep, innovative pi
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 61.14% | $6.18B | 0.35% |
PTH | 58.20% | $117.64M | 0.6% |
IBB | 54.01% | $6.41B | 0.45% |
PBE | 52.86% | $255.43M | 0.58% |
GNOM | 51.35% | $68.90M | 0.5% |
XPH | 49.19% | $155.81M | 0.35% |
IWC | 46.63% | $927.11M | 0.6% |
FBT | 46.00% | $1.17B | 0.56% |
BBH | 45.31% | $398.49M | 0.35% |
ARKG | 42.90% | $1.09B | 0.75% |
RSPA | 42.87% | $268.92M | 0% |
QQA | 42.76% | $145.15M | 0% |
IWO | 42.69% | $12.47B | 0.24% |
FTHI | 41.83% | $1.10B | 0.75% |
ISCG | 41.33% | $633.06M | 0.06% |
VTWO | 41.31% | $12.12B | 0.1% |
PINK | 41.22% | $139.16M | 0.5% |
IWM | 40.81% | $70.21B | 0.19% |
HYDB | 40.56% | $1.19B | 0.35% |
ESML | 40.26% | $1.87B | 0.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -24.36% | $195.31M | 0.85% |
CTA | -22.86% | $536.34M | 0.76% |
UUP | -12.94% | $640.67M | 0.77% |
TAIL | -12.32% | $65.48M | 0.59% |
USDU | -11.96% | $390.63M | 0.5% |
USCI | -11.29% | $200.39M | 1.07% |
DBA | -10.83% | $812.87M | 0.93% |
WEAT | -10.27% | $121.69M | 0.28% |
DBE | -9.09% | $50.63M | 0.77% |
BILZ | -8.33% | $616.87M | 0.14% |
CORN | -7.90% | $65.39M | 0.2% |
UNG | -7.80% | $820.81M | 1.06% |
COMT | -6.76% | $717.70M | 0.48% |
SOYB | -6.66% | $26.14M | 0.22% |
DBO | -6.62% | $228.06M | 0.77% |
GSG | -6.24% | $1.07B | 0.75% |
TPMN | -6.07% | $41.70M | 0.65% |
CCOR | -5.83% | $82.35M | 1.18% |
PDBC | -5.78% | $4.29B | 0.59% |
DBC | -5.43% | $1.35B | 0.87% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MINT | 0.05% | $12.01B | 0.35% |
FLOT | 0.27% | $7.88B | 0.15% |
IBMN | 0.28% | $484.21M | 0.18% |
AGZD | 0.43% | $142.77M | 0.23% |
DBB | 0.48% | $109.41M | 0.77% |
DUSB | 0.69% | $928.78M | 0.15% |
TBLL | -0.72% | $2.00B | 0.08% |
CPER | -0.79% | $152.96M | 0.97% |
SHV | -0.81% | $19.02B | 0.15% |
FLTR | 0.93% | $1.97B | 0.14% |
GCC | -1.49% | $132.73M | 0.55% |
TBIL | -1.81% | $4.81B | 0.15% |
XBIL | -2.02% | $642.09M | 0.15% |
XHLF | -2.09% | $940.17M | 0.03% |
BOXX | -2.13% | $4.73B | 0.1949% |
KMLM | 2.26% | $333.89M | 0.9% |
SHYD | -3.92% | $310.85M | 0.35% |
CMDY | -3.94% | $292.72M | 0.28% |
SGOV | -3.98% | $31.15B | 0.09% |
CANE | 4.13% | $12.08M | 0.29% |